Sara Gil Bernabé Email and Phone Number
Ilusión, compromiso y constancia
Ibgm - Csic/Uva
View- Employees:
- 11
-
Phd StudentIbgm - Csic/Uva Oct 2018 - PresentValladolid Y Alrededores, EspañaMedicina genómica, predictiva y personalizada en tumores tiroideos huérfanos, agresivos y metastásicos, resistentes a radioyodo. Identificación de biomarcadores diagnósticos, pronósticos y terapéuticos. -
Estudiante De Máster CientíficoIbgm - Csic/Uva Aug 2017 - Sep 2018Valladolid, Castilla-León, EspañaDesde agosto de 2017 pertenezco al grupo de investigación de Patobiología del Cáncer: Heterogeneidad inter-, intra-tumoral y Dianas Moleculares del Instituto de Biología y Genética Molecular (IBGM), Centro mixto Universidad de Valladolid - Consejo Superior de Investigaciones Científicas. Donde actualmente realizo mi TFM del Máster de Investigación Biomédica. Current projects are focused in: - The study dynamic changes in mutational load distribution (clonal diversity) that occur through space and time.- The identification of new molecular mechanisms governing, at the cellular level, the transformation of indolent, morphological indistinguishable differentiated Papillary Thyroid Carcinomas or minimally invasive differentiated Follicular Thyroid Carcinomas into highly aggressive Poorly Differentiated Thyroid Carcinomas or Undifferentiated / Anaplastic Thyroid Carcinomas- The identification and characterization of new signalling pathways and molecules involved in thyroid follicular cell neoplastic transformation, which exert a pivotal role in tumor maintenance, tumor progression (appearance of recurrences, cell migration, acquisition of metastatic properties, epithelial- mesenchymal transition, stemness perpetuation) and intrinsic or acquired resistance to conventional therapies or targeted drugs.- The identification of interactions / cross-talks between activated effectors of the RAS/BRAF/ERK pathway, the PI3K/AKT pathway, the Wnt pathway or the activated TERT promoter and other unknown molecules, which may exert a key role in the partial, self-limited response observed so far to kinase inhibitors and other targeted drugs given to patients with advanced, metastatic, radioiodine resistant papillary thyroid carcinomas, poorly differentiated thyroid carcinomas and undifferentiated / anaplastic thyroid carcinomas -
Visiting Phd StudentHarvard Medical School Sep 2022 - Dec 2022Boston, Massachusetts, Estados UnidosVisiting PhD Student at Landa Lab in Harvard Medical School and Brigham and Women’s Hospital -
Business Development TraineeAmadix Jan 2020 - Feb 2020Valladolid, Castilla Y León, EspañaPrácticas de Gestión de Proyectos de I+D+i -
Facultativo Análisis ClínicosHospital Universitario Río Hortega Aug 2016 - Sep 2016Valladolid, Castilla-León, EspañaRealicé mis prácticas curriculares en el departamento de Análisis clínicos del Hospital Universitario Río Hortega. Conocimientos en las áreas de recepción de muestras, bioquímica, serología, fluidos biológicos, inmunología y genética clínica.
Sara Gil Bernabé Education Details
-
Biological And Biomedical Sciences -
Diploma De Especialización En Oncología Traslacional -
Gestidi, Posgrado En Gestión De Proyectos I+D+I -
Biomedical Sciences, General -
Biomedical Sciences, General
Frequently Asked Questions about Sara Gil Bernabé
What company does Sara Gil Bernabé work for?
Sara Gil Bernabé works for Ibgm - Csic/uva
What is Sara Gil Bernabé's role at the current company?
Sara Gil Bernabé's current role is Ph.D. Candidate | Translational Oncology | Biotechnologist.
What schools did Sara Gil Bernabé attend?
Sara Gil Bernabé attended Universidad De Valladolid, Universidad Complutense De Madrid, Universidad Ceu San Pablo, Universidad De Valladolid, Universidad De León.
Not the Sara Gil Bernabé you were looking for?
Free Chrome Extension
Find emails, phones & company data instantly
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial